Digel Pharmaceuticals: Supervisory Committee\'s verification opinion on the first category of incentive recipients granted for the first time in the 2022 restricted stock incentive plan, and the first vesting period of the first vesting period

SZSI · Dec 19, 2023 00:00

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

迪哲医药：监事会关于2022年限制性股票激励计划首次授予部分的第一类激励对象第一个归属期归属名单的核查意见

Digel Pharmaceuticals: Supervisory Committee\'s verification opinion on the first category of incentive recipients granted for the first time in the 2022 restricted stock incentive plan, and the first vesting period of the first vesting period

Risk Disclaimer

Statement